GLASS LAB · Medical Aesthetics Evidence Index 303 cells · 19,226 papers · 5,969 top-tier evidence

Acne / Scar / Texture · Atrophic acne scar - rolling

Acellular dermal matrix ECM skinbooster evidence for Atrophic acne scar - rolling

D 33.8 / 100 Insufficient 0 RCT/meta · 0 clinical/observational · 0 case · 1 total
Insufficient evidence

There is not yet enough PubMed evidence for this combination. The procedure exists, but research on this indication may be scarce.

Grade combines the quantity and quality of the research, while direction is a separate signal showing how the papers assess effectiveness.

Median year 2024 Last 5 years 100% Positive results 100%

Known in Korea as

리투오셀르디엠리투오 파인엘라비에 리투오

Procedure and brand names vary, but the evidence above applies to the same procedure mechanism.

Key papers

tier_other Micronized acellular dermal matrix combined with platelet rich plasma in the treatment of atrophic acne scars: A self-controlled split face study. Journal of cosmetic dermatology · 2024 · PMID 38558364

Abstract summary (English) BACKGROUND: Micronized acellular dermal matrix (mADM) can induce tissue regeneration and repair, and filling. OBJECTIVES: The efficacy and safety of (mADM) were evaluated in the treatment of atrophic acne scar. METHODS: In this single-blinded, self-controlled, split-face study, 16 patients (48 scar sites) were divided into treatment group (24 scar sites) and control group (24 scar sites).

Journal Article

View on PubMed

Suggested interpretation

Minimal evidence

Personalized evidence report

Tell us more about your concern
and the Glass Lab bot will build a personalized report for you.

Based on the Acellular dermal matrix ECM skinbooster · Atrophic acne scar - rolling information on this page, we'll email you an evidence summary tailored to your skin condition and treatment stage.

Concerns of interest (select multiple)
Decision stage
← Other indications for the same procedure group  |  Other procedures for the same indication →